Current Report Filing (8-k)
17 Fevereiro 2023 - 8:02AM
Edgar (US Regulatory)
0001847846
false
0001847846
2023-02-16
2023-02-16
0001847846
LAX:OrdinarySharesMember
2023-02-16
2023-02-16
0001847846
LAX:RedeemableWarrantsMember
2023-02-16
2023-02-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 16, 2023 (February 15, 2023)
EUDA
Health Holdings Limited
(Exact
name of registrant as specified in its charter)
British
Virgin Islands |
|
001-40678 |
|
n/a |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
1
Pemimpin Drive #12-07
One
Pemimpin Singapore 576151
(Address
of Principal Executive Offices and Zip Code)
Registrant’s
telephone number including area code: +65 6268 6821
n/a
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
|
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
|
|
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |
Title of
each class |
|
Trading Symbol(s) |
|
Name of each
exchange on which registered |
|
|
|
|
|
Ordinary Shares |
|
EUDA |
|
NASDAQ Stock Market LLC
|
Redeemable Warrants |
|
EUDAW |
|
NASDAQ Stock Market LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Section
5 - Corporate Governance and Management
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
Change
of the Chairman of the Board
On
February 15, 2023, Mr. Thien Su Gerald Lim, resigned from his position as the Chairman of the Board of Directors (the “Board”)
of EUDA Health Holdings Limited (the “Company”), effective immediately. Mr. Lim will continue to serve
as a director of the Company, a member of the Audit Committee, and a member of the Corporate Governance and Nominating Committee. Mr.
Lim’s resignation from the Chairman position was not a result of any disagreement with the Company regarding its operations, policies
or practices.
In conjunction with Mr. Lim’s
resignation, Mr. David Francis Capes, a member of the Board, was appointed to serve as Chairman of the Board. In addition to serving
as the Chairman of the Board, Mr. Capes remains as Chairman of the Audit Committee, a member of
the Corporate Governance and Nominating Committee, and a member of the Compensation Committee.
Appointment
of a New Director
As
previously disclosed in the Company’s Current Report on Form 8-K filed on January 31, 2023, effective January 25, 2023, Mr. Kim
Hing Chan resigned as a member of the Board of Directors of the Company. Mr. Chan’s resignation from the aforementioned position
was not a result of any disagreement with the Company regarding its operations, policies or practices.
On February 15, 2023, Mr. Chee Hyong Leonard Chia accepted the appointment
to serve as a Class II director of the Company to fill in the vacancy as result of Mr. Chan’s resignation, effective immediately.
Mr. Chia has over 30 years of experience in legal practice. Mr. Chia was a co-managing director of Asia Ascent Law Corporation from January
2006 to December 2010, and has been the sole managing director since January 2011. From January 2003 to January 2006, Mr. Chia was the
sole proprietor of CCH Leo & Co. From 1997 to 2002, Mr. Chia was a partner in Sterling Law Corporation. Mr. Chia has been a member
of Singapore Bar since 1991. He is a Barrister-at-Law and has been a member of the Bar of England and Wales in 1989. Mr. Chia is a member
of Law Society of Singapore, Singapore Academy of Law, and the Maritime Law Association of Singapore. Mr. Chia currently also serves as
an associate mediator in Singapore Mediation Centre and an associate mediator to the inaugural panel of mediators for the law society
mediation scheme of the Law Society of Singapore. Mr. Chia holds a Post Graduate Diploma in Law from City University of London and a Bachelor
of Science in business studies from University of Buckingham. The Company believes that Mr. Chia qualified as an independent director.
There
is no arrangement or understanding between Mr. Chia and any other person pursuant to which Mr. Chia was selected as a director. Mr. Chia
does not have any family relationship with any director, executive officer or person nominated or chosen by the Company to become a director
or an executive officer. The Board has determined that Mr. Chia is an independent director under applicable Nasdaq rules.
Mr.
Chia has agreed to serve as a Class II director until the reelection by the shareholders of the Company or earlier removal or resignation,
and not to receive any compensation in connection with his service as a Class II director. The Company has agreed to reimburse his reasonable
expenses in connection with his service.
A
copy of Mr. Chia’s offer letter is included as Exhibit 99.1.
Section
9 - Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
EUDA Health Holdings Limited |
|
|
|
Date: February 16, 2023 |
By: |
/s/
David Francis Capes |
|
Name: |
David Francis Capes |
|
Title: |
Chairman of the Board |
Euda Health (NASDAQ:EUDA)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Euda Health (NASDAQ:EUDA)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024